Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05425979
Other study ID # 22-000140
Secondary ID
Status Enrolling by invitation
Phase Phase 4
First received
Last updated
Start date March 11, 2024
Est. completion date December 2024

Study information

Verified date March 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to determine if both local anesthetics (mepivacaine and bupivacaine) are similar in their onset of sensory block to assess the efficiency of ultrasound-guided ankle blocks in our practice. Currently it is the standard of care to perform ankles blocks with both mepivacaine and bupivacaine. However, given similarity in their safety profile researchers would like to compare if one is non-inferior to the other in terms of onset time of ankle block.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 50
Est. completion date December 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age greater than or equal to 18 years old. - Patients who provide informed consent to participate. - Patients undergoing foot surgery who require a peripheral nerve block of the ankle as primary anesthesia. - ASA (American Society of Anesthesiology) Physical Status Classification I - III. Exclusion Criteria: - Inability to consent. - Allergy to local anesthetic. - Infection at site of injection. - Pregnancy. - Coagulopathy. - Hepatic or renal failure. - Preexisting neuropathy in operative limb. - Planned spinal anesthetic or general anesthesia.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Mepivacaine
Up to two 30 ml vials of mepivacaine 1.5% via ultrasound-guided nerve blockade of the tibial and deep peroneal nerves
Bupivacaine
Up to two 30 ml vials of bupivacaine 0.5% via ultrasound-guided nerve blockade of the tibial and deep peroneal nerves

Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Onset of sensory Blockage Time in minutes for successful surgical sensory blockade following the ankle block 20 minutes
Secondary Block Failure Number of subjects to experience block failure as defined as opioid administration operatively and /or conversion to general anesthesia 20 minutes
Secondary Pain Scores Pain scores in post-anesthesia care unit (PACU) will be obtained using the numerical rating scale (0-10 point scale with 0 representing no pain and 10 representing the worst possible pain) Post-procedural, approximately 2-4 hours
Secondary Total opioid received intra-operatively Total amount of opioid received intra-operatively Intra-operatively, approximately 4-6 hours
Secondary Time to first opioid use Time measured in minutes to the first opioid use 24 hours
Secondary Number of complications Total number of procedural complications 24 hour
Secondary Total anesthesia-related time Measured in minutes, defined as performance time plus onset time of local anesthesia 20 minutes
Secondary Overall Benefit of Analgesia Score (OBAS) Seven questions to access pain intensity, adverse effects and satisfaction with treatment. Possible score range from 0 to 24, with higher scores indicating worse outcome 24 hours after discharge
Secondary Total opioid use after discharge Total amount of opioids used used for pain control after discharge 24 hours after discharge
Secondary Duration of the ankle block Length of time measured in minutes the patient to felt until the ankle block completely wore off 24 hours after discharge
See also
  Status Clinical Trial Phase
Completed NCT01229696 - Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia Phase 4
Completed NCT01049906 - Popliteal Sciatic Nerve Block Catheter Placement for Foot Surgery N/A
Terminated NCT05354791 - Pre-post Spinal Popliteal Block
Terminated NCT01325012 - Ultrasound-Guided Continuous Sciatic Nerve Blocks: Popliteal Versus Subgluteal Catheters Phase 4
Terminated NCT01615939 - A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block Phase 4
Enrolling by invitation NCT06465992 - Liposomal Bupivacaine With Dexamethasone for Foot Surgery Phase 4
Completed NCT05368012 - MIDCAB (Mid-Calf Block) for Foot Surgery Phase 4
Enrolling by invitation NCT04575688 - Periarticular Injection Versus Popliteal Block Phase 4
Recruiting NCT01546077 - Placement of Perineural Catheters in the Popliteal Region Phase 4
Recruiting NCT06309381 - Influence of Sensory Block Duration on Rebound Pain After Outpatient Foot Surgery Under Popliteal Sciatic Nerve Block.
Completed NCT04134962 - Evaluation of a New Tool for Measuring Hindfoot Alignment Under Load and in 3D.
Enrolling by invitation NCT04872322 - Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery Phase 3